 Elizabeth Juarez-Colunga
Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 5 | 2022 | 103 | 1.280 |
Why?
| | Vigabatrin | 2 | 2022 | 18 | 0.910 |
Why?
| | Models, Statistical | 4 | 2017 | 595 | 0.820 |
Why?
| | Machine Learning | 2 | 2021 | 315 | 0.750 |
Why?
| | Pseudomonas Infections | 2 | 2022 | 184 | 0.740 |
Why?
| | Isoantibodies | 1 | 2021 | 52 | 0.720 |
Why?
| | Graft Rejection | 2 | 2021 | 511 | 0.720 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 54 | 0.620 |
Why?
| | Vaccination Coverage | 1 | 2019 | 63 | 0.600 |
Why?
| | Cystic Fibrosis | 4 | 2022 | 955 | 0.580 |
Why?
| | Behavior Therapy | 2 | 2019 | 225 | 0.580 |
Why?
| | Papillomavirus Vaccines | 1 | 2019 | 222 | 0.510 |
Why?
| | Health Education | 1 | 2019 | 317 | 0.510 |
Why?
| | Risk Assessment | 5 | 2019 | 2958 | 0.510 |
Why?
| | Papillomavirus Infections | 1 | 2019 | 261 | 0.500 |
Why?
| | Internet | 2 | 2020 | 591 | 0.500 |
Why?
| | Algorithms | 2 | 2021 | 1469 | 0.490 |
Why?
| | Longitudinal Studies | 4 | 2017 | 2384 | 0.460 |
Why?
| | Epilepsies, Myoclonic | 3 | 2018 | 41 | 0.420 |
Why?
| | Treatment Outcome | 8 | 2022 | 9049 | 0.420 |
Why?
| | Data Mining | 1 | 2014 | 100 | 0.410 |
Why?
| | Humans | 64 | 2024 | 114049 | 0.410 |
Why?
| | Postoperative Complications | 6 | 2018 | 2122 | 0.400 |
Why?
| | Down Syndrome | 3 | 2021 | 335 | 0.390 |
Why?
| | Epileptic Syndromes | 3 | 2021 | 66 | 0.370 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1471 | 0.360 |
Why?
| | Osteoarthritis, Knee | 2 | 2023 | 212 | 0.350 |
Why?
| | Family Planning Services | 2 | 2022 | 68 | 0.340 |
Why?
| | Biomarkers | 4 | 2021 | 3397 | 0.330 |
Why?
| | Contraception | 2 | 2022 | 117 | 0.330 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2537 | 0.330 |
Why?
| | Tacrolimus | 2 | 2021 | 134 | 0.320 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 926 | 0.320 |
Why?
| | Vision Disorders | 2 | 2021 | 127 | 0.320 |
Why?
| | Female | 41 | 2023 | 59326 | 0.320 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2022 | 246 | 0.300 |
Why?
| | Research Design | 1 | 2013 | 919 | 0.300 |
Why?
| | Anticonvulsants | 2 | 2022 | 178 | 0.290 |
Why?
| | Child | 17 | 2022 | 18404 | 0.280 |
Why?
| | Advance Care Planning | 3 | 2020 | 195 | 0.280 |
Why?
| | Male | 34 | 2023 | 55398 | 0.260 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 24 | 0.260 |
Why?
| | Developmental Disabilities | 2 | 2019 | 236 | 0.250 |
Why?
| | Hospitalization | 4 | 2020 | 1762 | 0.250 |
Why?
| | Quality Improvement | 6 | 2019 | 944 | 0.250 |
Why?
| | Primary Health Care | 3 | 2020 | 1502 | 0.230 |
Why?
| | Walking | 3 | 2024 | 422 | 0.230 |
Why?
| | Preoperative Care | 2 | 2016 | 319 | 0.230 |
Why?
| | Retrospective Studies | 15 | 2021 | 12521 | 0.220 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 16 | 0.220 |
Why?
| | Veterans | 3 | 2024 | 1248 | 0.220 |
Why?
| | Surgical Procedures, Operative | 2 | 2016 | 206 | 0.210 |
Why?
| | Logistic Models | 4 | 2021 | 1829 | 0.200 |
Why?
| | Group Processes | 2 | 2020 | 53 | 0.200 |
Why?
| | Patient Readmission | 2 | 2018 | 607 | 0.200 |
Why?
| | Adolescent | 15 | 2021 | 17802 | 0.200 |
Why?
| | Cosyntropin | 1 | 2022 | 4 | 0.200 |
Why?
| | Hospital Mortality | 2 | 2016 | 773 | 0.200 |
Why?
| | Spasm | 1 | 2022 | 19 | 0.200 |
Why?
| | Exercise Therapy | 2 | 2024 | 351 | 0.190 |
Why?
| | Disease Progression | 4 | 2022 | 2371 | 0.190 |
Why?
| | Kidney Pelvis | 1 | 2021 | 19 | 0.180 |
Why?
| | Adult | 17 | 2021 | 30377 | 0.180 |
Why?
| | Aged | 16 | 2023 | 18971 | 0.180 |
Why?
| | Amputees | 1 | 2021 | 62 | 0.180 |
Why?
| | Ureteral Obstruction | 1 | 2021 | 54 | 0.180 |
Why?
| | Markov Chains | 2 | 2019 | 114 | 0.170 |
Why?
| | Monte Carlo Method | 2 | 2019 | 136 | 0.170 |
Why?
| | Mobile Applications | 1 | 2022 | 140 | 0.170 |
Why?
| | ROC Curve | 1 | 2021 | 441 | 0.170 |
Why?
| | Inpatients | 3 | 2021 | 378 | 0.170 |
Why?
| | United States | 14 | 2021 | 12137 | 0.170 |
Why?
| | Text Messaging | 1 | 2022 | 152 | 0.170 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 641 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 110 | 0.170 |
Why?
| | Resuscitation Orders | 1 | 2020 | 45 | 0.160 |
Why?
| | Postnatal Care | 1 | 2019 | 65 | 0.160 |
Why?
| | Head and Neck Neoplasms | 1 | 2023 | 427 | 0.160 |
Why?
| | Rural Health Services | 1 | 2019 | 92 | 0.160 |
Why?
| | Gait | 1 | 2021 | 250 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 217 | 0.160 |
Why?
| | Graft Survival | 1 | 2021 | 443 | 0.160 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1078 | 0.150 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2159 | 0.150 |
Why?
| | Medical History Taking | 1 | 2019 | 115 | 0.150 |
Why?
| | Brain Waves | 1 | 2018 | 20 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 94 | 0.150 |
Why?
| | Hospital Costs | 1 | 2019 | 104 | 0.150 |
Why?
| | Mental Disorders | 2 | 2016 | 889 | 0.150 |
Why?
| | Postoperative Care | 2 | 2017 | 223 | 0.150 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 118 | 0.150 |
Why?
| | Young Adult | 8 | 2020 | 10446 | 0.150 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 150 | 0.150 |
Why?
| | Automobile Driver Examination | 1 | 2017 | 10 | 0.150 |
Why?
| | Antibody Formation | 1 | 2019 | 266 | 0.150 |
Why?
| | Community Health Services | 1 | 2019 | 212 | 0.150 |
Why?
| | Pregnant Women | 1 | 2019 | 129 | 0.150 |
Why?
| | Smoking Cessation | 1 | 2021 | 374 | 0.150 |
Why?
| | Symptom Assessment | 1 | 2019 | 119 | 0.150 |
Why?
| | Lung | 3 | 2023 | 3521 | 0.140 |
Why?
| | Computer Simulation | 1 | 2021 | 873 | 0.140 |
Why?
| | Transgender Persons | 1 | 2020 | 134 | 0.140 |
Why?
| | Automobile Driving | 2 | 2016 | 129 | 0.140 |
Why?
| | Thoracoscopy | 1 | 2017 | 49 | 0.140 |
Why?
| | Thyrotropin | 1 | 2017 | 100 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2023 | 4402 | 0.140 |
Why?
| | Aged, 80 and over | 8 | 2021 | 6307 | 0.140 |
Why?
| | Tissue Donors | 1 | 2019 | 314 | 0.140 |
Why?
| | Patient Participation | 1 | 2020 | 348 | 0.140 |
Why?
| | Esophagectomy | 1 | 2018 | 110 | 0.140 |
Why?
| | Cross Infection | 1 | 2019 | 194 | 0.140 |
Why?
| | Middle Aged | 14 | 2023 | 26607 | 0.140 |
Why?
| | Croup | 1 | 2017 | 22 | 0.140 |
Why?
| | Polysomnography | 1 | 2017 | 136 | 0.140 |
Why?
| | Obesity | 2 | 2019 | 2505 | 0.140 |
Why?
| | Hydrocarbons | 1 | 2016 | 29 | 0.130 |
Why?
| | Organ Transplantation | 1 | 2019 | 159 | 0.130 |
Why?
| | Construction Industry | 1 | 2016 | 15 | 0.130 |
Why?
| | Air Pollutants, Occupational | 1 | 2016 | 27 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 298 | 0.130 |
Why?
| | Decision Support Techniques | 1 | 2020 | 336 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2017 | 121 | 0.130 |
Why?
| | Hormone Replacement Therapy | 1 | 2017 | 76 | 0.130 |
Why?
| | Delivery of Health Care | 2 | 2020 | 828 | 0.130 |
Why?
| | Heart Arrest | 1 | 2020 | 293 | 0.130 |
Why?
| | Body Composition | 1 | 2020 | 590 | 0.130 |
Why?
| | Medicaid | 2 | 2020 | 404 | 0.130 |
Why?
| | Risk Factors | 6 | 2019 | 8614 | 0.130 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 128 | 0.130 |
Why?
| | Health Resources | 1 | 2017 | 120 | 0.130 |
Why?
| | Telemedicine | 1 | 2024 | 662 | 0.130 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 222 | 0.130 |
Why?
| | Ultrasonography | 1 | 2019 | 635 | 0.130 |
Why?
| | Infant | 8 | 2021 | 7944 | 0.120 |
Why?
| | Epilepsy | 1 | 2019 | 278 | 0.120 |
Why?
| | Treatment Failure | 1 | 2016 | 330 | 0.120 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 286 | 0.120 |
Why?
| | Child, Preschool | 8 | 2021 | 9115 | 0.120 |
Why?
| | Physician-Patient Relations | 2 | 2016 | 459 | 0.120 |
Why?
| | Data Collection | 1 | 2017 | 618 | 0.120 |
Why?
| | Rehabilitation Centers | 1 | 2015 | 32 | 0.120 |
Why?
| | General Surgery | 1 | 2016 | 125 | 0.120 |
Why?
| | Perception | 1 | 2017 | 309 | 0.120 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 87 | 0.120 |
Why?
| | Nutrition Surveys | 1 | 2016 | 225 | 0.120 |
Why?
| | Independent Living | 1 | 2015 | 84 | 0.120 |
Why?
| | Esophageal Neoplasms | 1 | 2018 | 270 | 0.120 |
Why?
| | Life Change Events | 1 | 2015 | 135 | 0.120 |
Why?
| | DNA Damage | 1 | 2016 | 351 | 0.110 |
Why?
| | Patient Admission | 1 | 2016 | 175 | 0.110 |
Why?
| | Testosterone | 1 | 2017 | 341 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 195 | 0.110 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 522 | 0.110 |
Why?
| | Hospitals | 2 | 2016 | 581 | 0.110 |
Why?
| | Vaccines | 1 | 2019 | 375 | 0.110 |
Why?
| | Insurance, Health | 1 | 2016 | 243 | 0.110 |
Why?
| | Occupational Exposure | 1 | 2016 | 255 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 6077 | 0.110 |
Why?
| | Poisson Distribution | 1 | 2013 | 71 | 0.110 |
Why?
| | Parents | 2 | 2021 | 1181 | 0.110 |
Why?
| | Physician's Role | 1 | 2015 | 192 | 0.110 |
Why?
| | Nursing Homes | 1 | 2015 | 138 | 0.110 |
Why?
| | Kidney Transplantation | 1 | 2019 | 538 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2014 | 177 | 0.110 |
Why?
| | Prospective Studies | 2 | 2022 | 6195 | 0.110 |
Why?
| | Databases, Factual | 4 | 2018 | 1125 | 0.100 |
Why?
| | Walk Test | 2 | 2023 | 52 | 0.100 |
Why?
| | Body Mass Index | 1 | 2020 | 1957 | 0.100 |
Why?
| | Recovery of Function | 3 | 2022 | 573 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2016 | 372 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2014 | 452 | 0.100 |
Why?
| | Cohort Studies | 5 | 2021 | 4883 | 0.100 |
Why?
| | Patient Discharge | 2 | 2015 | 770 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2016 | 479 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1072 | 0.100 |
Why?
| | Length of Stay | 4 | 2018 | 957 | 0.100 |
Why?
| | Histones | 1 | 2016 | 529 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 4595 | 0.100 |
Why?
| | Single-Blind Method | 2 | 2021 | 259 | 0.090 |
Why?
| | Vaccination | 1 | 2019 | 1202 | 0.090 |
Why?
| | Recurrence | 1 | 2013 | 925 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2015 | 430 | 0.090 |
Why?
| | Child Abuse | 1 | 2015 | 456 | 0.090 |
Why?
| | Interferon-gamma | 1 | 2014 | 719 | 0.090 |
Why?
| | Age Factors | 4 | 2019 | 2885 | 0.080 |
Why?
| | Influenza Vaccines | 1 | 2014 | 497 | 0.080 |
Why?
| | Brain Concussion | 1 | 2016 | 477 | 0.080 |
Why?
| | Preventive Health Services | 2 | 2020 | 134 | 0.080 |
Why?
| | Sex Factors | 3 | 2020 | 1706 | 0.080 |
Why?
| | Cognition | 1 | 2016 | 990 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 1726 | 0.080 |
Why?
| | Postoperative Period | 2 | 2021 | 288 | 0.080 |
Why?
| | Guatemala | 2 | 2019 | 267 | 0.080 |
Why?
| | Comorbidity | 3 | 2017 | 1447 | 0.070 |
Why?
| | Electroencephalography | 2 | 2021 | 359 | 0.070 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2017 | 15 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2022 | 735 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1204 | 0.070 |
Why?
| | Mothers | 2 | 2022 | 650 | 0.070 |
Why?
| | Morbidity | 2 | 2019 | 277 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1958 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1735 | 0.070 |
Why?
| | Pilot Projects | 2 | 2020 | 1360 | 0.060 |
Why?
| | Survival Rate | 2 | 2020 | 1638 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2016 | 1815 | 0.060 |
Why?
| | Vulnerable Populations | 1 | 2023 | 129 | 0.050 |
Why?
| | Pregnancy | 3 | 2019 | 5499 | 0.050 |
Why?
| | Electronic Health Records | 2 | 2020 | 799 | 0.050 |
Why?
| | Pseudomonas | 1 | 2022 | 26 | 0.050 |
Why?
| | Socioeconomic Factors | 2 | 2016 | 1080 | 0.050 |
Why?
| | Cotinine | 1 | 2021 | 69 | 0.050 |
Why?
| | Milk, Human | 1 | 2022 | 127 | 0.050 |
Why?
| | Hydronephrosis | 1 | 2021 | 28 | 0.050 |
Why?
| | Smoking Prevention | 1 | 2021 | 157 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 94 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 95 | 0.040 |
Why?
| | Quadriceps Muscle | 1 | 2021 | 104 | 0.040 |
Why?
| | Urologic Surgical Procedures | 1 | 2021 | 94 | 0.040 |
Why?
| | Home Health Nursing | 1 | 2019 | 9 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 275 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2020 | 132 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4090 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4392 | 0.040 |
Why?
| | Breast Feeding | 1 | 2022 | 366 | 0.040 |
Why?
| | Reproductive Health | 1 | 2019 | 70 | 0.040 |
Why?
| | Muscle Strength | 1 | 2021 | 271 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 200 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2021 | 669 | 0.040 |
Why?
| | Documentation | 1 | 2020 | 166 | 0.040 |
Why?
| | Mentoring | 1 | 2020 | 99 | 0.040 |
Why?
| | House Calls | 1 | 2019 | 115 | 0.040 |
Why?
| | Safety-net Providers | 1 | 2019 | 96 | 0.040 |
Why?
| | Lower Extremity | 1 | 2021 | 334 | 0.040 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 492 | 0.040 |
Why?
| | Choice Behavior | 1 | 2019 | 150 | 0.040 |
Why?
| | Snoring | 1 | 2017 | 12 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 130 | 0.040 |
Why?
| | Women's Health | 1 | 2019 | 270 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2019 | 339 | 0.040 |
Why?
| | Perioperative Period | 1 | 2017 | 47 | 0.040 |
Why?
| | Cesarean Section | 1 | 2019 | 169 | 0.040 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 222 | 0.040 |
Why?
| | Preoperative Period | 1 | 2017 | 102 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 3338 | 0.030 |
Why?
| | Oximetry | 1 | 2017 | 79 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 151 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 396 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2016 | 26 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 180 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 17 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 545 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 544 | 0.030 |
Why?
| | Housing for the Elderly | 1 | 2015 | 5 | 0.030 |
Why?
| | Rural Population | 1 | 2019 | 443 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 661 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 513 | 0.030 |
Why?
| | Financing, Personal | 1 | 2015 | 24 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 257 | 0.030 |
Why?
| | Health Surveys | 1 | 2017 | 441 | 0.030 |
Why?
| | Depression | 1 | 2023 | 1133 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 160 | 0.030 |
Why?
| | Probability | 1 | 2016 | 286 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 675 | 0.030 |
Why?
| | Lymphocytes | 1 | 2016 | 327 | 0.030 |
Why?
| | Weight Loss | 1 | 2019 | 642 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2016 | 255 | 0.030 |
Why?
| | Risk | 1 | 2017 | 810 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2016 | 175 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1382 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2016 | 471 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 2017 | 254 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1791 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2016 | 318 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2016 | 285 | 0.030 |
Why?
| | Life Style | 1 | 2016 | 428 | 0.030 |
Why?
| | Health Services Research | 1 | 2016 | 373 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1690 | 0.030 |
Why?
| | Body Weight | 1 | 2017 | 868 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 541 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2017 | 614 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 556 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3003 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2343 | 0.030 |
Why?
| | Oxygen | 1 | 2017 | 851 | 0.030 |
Why?
| | Surgeons | 1 | 2016 | 236 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1764 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3315 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 478 | 0.020 |
Why?
| | Sleep | 1 | 2017 | 631 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 926 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2016 | 476 | 0.020 |
Why?
| | Cognitive Dysfunction | 1 | 2016 | 282 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2764 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 5038 | 0.020 |
Why?
|
|
Juarez-Colunga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|